Thomas L. Steinacker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas L. Steinacker has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Schleiffer
Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria
51 shared publications - Anna C. Obenauf
Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria
51 shared publications - Arno Rütten
13Dermatopathology Friedrichshafen, Friedrichshafen, Germany
51 shared publications - Babak Itzinger-Monshi
Department of Dermatology, Rudolfstiftung Hospital, Vienna, Austria
51 shared publications - Eduardo Calonje
Department of Dermatopathology St John's Institute of Dermatology, St Thomas's Hospital London UK
51 shared publications - Estelle Laurent
Univ.Lille, CHU Lille, Inserm U1192, Protéomique Réponse Inflammatoire Spectrométrie de Masse (PRISM), Lille, France
51 shared publications
Latest Publications
- 3 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6815)
Conformational asymmetry of replicated human chromosomes
DNA replication generates sister chromatids with identical sequence, yet its mechanism is fundamentally asymmetric: Chromatids inherit strands of opposite orientation, whereas forks synthesize new strands by distinct leading- and lagging-strand mechanisms. How this replication asymmetry affects chromosome organization is unknown. Using sister chromatid–sensitive conformation analysis, we found that human sister chromatids are consistently misaligned in the 5′→3′ direction of inherited DNA strands. This shift persisted without cohesin-mediated loop extrusion but was lost upon disruption of cohesion. Polymer modeling showed that modest directional misalignment of cohesive cohesins can explain the observed shift, and we propose two models for how such misalignment could originate from replication fork asymmetry. This register shift between sister chromatids has implications for homology search during DNA repair.
- 3 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6815)
Conformational asymmetry of replicated human chromosomes
DNA replication generates sister chromatids with identical sequence, yet its mechanism is fundamentally asymmetric: Chromatids inherit strands of opposite orientation, whereas forks synthesize new strands by distinct leading- and lagging-strand mechanisms. How this replication asymmetry affects chromosome organization is unknown. Using sister chromatid–sensitive conformation analysis, we found that human sister chromatids are consistently misaligned in the 5′→3′ direction of inherited DNA strands. This shift persisted without cohesin-mediated loop extrusion but was lost upon disruption of cohesion. Polymer modeling showed that modest directional misalignment of cohesive cohesins can explain the observed shift, and we propose two models for how such misalignment could originate from replication fork asymmetry. This register shift between sister chromatids has implications for homology search during DNA repair.
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Figure 2 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
HPV42 induces transformation in vitro and tumor growth in vivo. A, Growth curves of HPKs transduced with the full genome of HPV11 (low-risk), HPV16 (high-risk), and HPV42. B, Crystal violet staining of MEF cells at day 14 after transduction. Scale bars, 100 μm. C, HPV42-E7 protein interaction partners identified in BioID proximity-labeling experiment. Pathway members of gene ontology terms G1–S transition (red) and HIPPO pathway (blue) are labeled. FC, fold change. D, E2F reporter assay in U2OS cells transduced with E7 proteins of HPV11, 16, or 42. ***, P < 0.001; ****, P < 0.0001 (one-way ANOVA, Tukey multiple comparisons test). E, Gene set enrichment analysis (GSEA) of the Molecular Signatures Database (MSigDB) hallmark gene set (top) and MSigDB curated gene set (bottom) comparing HPV42-E7 versus EV-transduced HPK cells. dev., development; NES, normalized enrichment score. F, IHC for YAP1 in a DPA tumor. Scale bar, main: 50 μm; inset: 3 mm. G, Individual tumor growth of EV- or E7 of HPV11-, HPV16-, or HPV42-transduced HaCaT cells in NSG mice. Each group consists of 5 mice (i.e., 10 tumors).
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
HPV42 induces transformation in vitro and tumor growth in vivo. A, Growth curves of HPKs transduced with the full genome of HPV11 (low-risk), HPV16 (high-risk), and HPV42. B, Crystal violet staining of MEF cells at day 14 after transduction. Scale bars, 100 μm. C, HPV42-E7 protein interaction partners identified in BioID proximity-labeling experiment. Pathway members of gene ontology terms G1–S transition (red) and HIPPO pathway (blue) are labeled. FC, fold change. D, E2F reporter assay in U2OS cells transduced with E7 proteins of HPV11, 16, or 42. ***, P < 0.001; ****, P < 0.0001 (one-way ANOVA, Tukey multiple comparisons test). E, Gene set enrichment analysis (GSEA) of the Molecular Signatures Database (MSigDB) hallmark gene set (top) and MSigDB curated gene set (bottom) comparing HPV42-E7 versus EV-transduced HPK cells. dev., development; NES, normalized enrichment score. F, IHC for YAP1 in a DPA tumor. Scale bar, main: 50 μm; inset: 3 mm. G, Individual tumor growth of EV- or E7 of HPV11-, HPV16-, or HPV42-transduced HaCaT cells in NSG mice. Each group consists of 5 mice (i.e., 10 tumors).
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Figure 1 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
HPV42 is associated with DPA. A, Overview of unbiased screening approach for detection of vertebrate-infecting viruses in targeted next-generation sequencing (NGS) data. Targeted NGS data from 18 skin tumor types and MCC (positive control, pos. ctrl.) were analyzed with the centrifuge metagenomic classifier utilizing a custom viral database (Viral DB). B, Virus abundance score in targeted NGS data of 214 human tumor samples. Detection of HPV42 in 100% (n = 11/11) of DPA samples. ACC, adenoid cystic carcinoma; AFX, atypical fibroxanthoma; AS, angiosarcoma; BPDCN, blastic plasmacytoid dendritic cell neoplasm; DM, desmoplastic melanoma; DTE, desmoplastic trichoepithelioma; EPC, eccrine porocarcinoma; ES, eccrine spiradenoma; LM, lentigo maligna melanoma; MAC, microcystic adnexal carcinoma; PM, pediatric melanoma; PPT, proliferating pilar cystic tumor; SAC, spiradenocarcinoma; SC, sebaceous carcinoma; SGC, sweat gland carcinoma; SKCM, cutaneous melanoma. Viral prevalence: proportion of samples with detected virus in any given tumor type. Abundance score: mean proportion of detected virus in any given tumor type. C, HPV42 abundance score in a cohort of 17 DPAs after sequence capture to DNA and RNA of 6,453 viruses. White diamond: HPV42 detected but below an abundance of 1%. ND, not determined. D, Top, Circos plot depicting HPV42–human genome breakpoints. Each arch represents one detected breakpoint. Bottom, lollipop presentation of integration breakpoints in the HPV42 genome. Each lollipop represents one breakpoint (Supplementary Table S4). E, FISH signal of HPV42 genome (magenta) and human genome integration site adjacent locus (yellow) in DPA nuclei (blue). White arrowheads indicate fusion signals. Scale bar, 2.5 μm. Individual channels and quantifications in Supplementary Fig. S4. F, Top, RNA-ISH staining for expression of early region HPV42 mRNA in lung metastasis of a DPA tumor (T) and the surrounding normal (N) tissue. Scale bar, 1 mm. Bottom, inset. Scale bar, 20 μm.
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 1 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
HPV42 is associated with DPA. A, Overview of unbiased screening approach for detection of vertebrate-infecting viruses in targeted next-generation sequencing (NGS) data. Targeted NGS data from 18 skin tumor types and MCC (positive control, pos. ctrl.) were analyzed with the centrifuge metagenomic classifier utilizing a custom viral database (Viral DB). B, Virus abundance score in targeted NGS data of 214 human tumor samples. Detection of HPV42 in 100% (n = 11/11) of DPA samples. ACC, adenoid cystic carcinoma; AFX, atypical fibroxanthoma; AS, angiosarcoma; BPDCN, blastic plasmacytoid dendritic cell neoplasm; DM, desmoplastic melanoma; DTE, desmoplastic trichoepithelioma; EPC, eccrine porocarcinoma; ES, eccrine spiradenoma; LM, lentigo maligna melanoma; MAC, microcystic adnexal carcinoma; PM, pediatric melanoma; PPT, proliferating pilar cystic tumor; SAC, spiradenocarcinoma; SC, sebaceous carcinoma; SGC, sweat gland carcinoma; SKCM, cutaneous melanoma. Viral prevalence: proportion of samples with detected virus in any given tumor type. Abundance score: mean proportion of detected virus in any given tumor type. C, HPV42 abundance score in a cohort of 17 DPAs after sequence capture to DNA and RNA of 6,453 viruses. White diamond: HPV42 detected but below an abundance of 1%. ND, not determined. D, Top, Circos plot depicting HPV42–human genome breakpoints. Each arch represents one detected breakpoint. Bottom, lollipop presentation of integration breakpoints in the HPV42 genome. Each lollipop represents one breakpoint (Supplementary Table S4). E, FISH signal of HPV42 genome (magenta) and human genome integration site adjacent locus (yellow) in DPA nuclei (blue). White arrowheads indicate fusion signals. Scale bar, 2.5 μm. Individual channels and quantifications in Supplementary Fig. S4. F, Top, RNA-ISH staining for expression of early region HPV42 mRNA in lung metastasis of a DPA tumor (T) and the surrounding normal (N) tissue. Scale bar, 1 mm. Bottom, inset. Scale bar, 20 μm.
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S13 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
HPV42 genome sequence comparison.
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S13 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
HPV42 genome sequence comparison.
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S9 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
Supplementary data depicted in Supplementary Figures S1-S9
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S9 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
Supplementary data depicted in Supplementary Figures S1-S9
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Figure 3 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
Oncogenic HPVs induce a germ cell–like transcriptional program conserved throughout HPV-driven cancers. A, Overview of the random forest (RF) feature selection and machine learning procedure to identify a transcriptional fingerprint of HPV-driven oncogenesis. CESC and HNSCC expression data were annotated with HPV status (data acquisition), commonly differentially expressed genes between HPV+ and HPV− were identified (data preparation), and 12 protein-coding signature genes (RF12) were identified (feature selection). Four different machine learning models were trained with RF12 on a subset of DPA, CESC, and HNSCC samples (model training); the model with the best hyperparameters was evaluated using the withheld sample subset and used to classify Genotype-Tissue Expression (GTEx), skin warts, or normal skin expression data (deployment). B, Contribution of RF12 signature genes to cumulative feature importance (%) to discriminate between HPV+ and HPV− tumor samples. C, Uniform manifold approximation and projection (UMAP) dimensionality reduction of RF12 expression in DPA, CESC, HNSCC, and skin warts. D, HPV+ probability scores were calculated by RF12 for CESC, HNSCC, DPA, skin warts, and normal skin. For CESC, HNSCC, and DPA, the test set samples are displayed. E, HPV+ probability scores for HNSCC calculated for CDKN2A and SYCP2 alone, the combination of CDKN2A and SYCP2 (RF2), and RF12. F, HPV+ probability scores were calculated by RF12 for 31 normal tissues obtained from the GTEx database. G, Expression levels of RF12 genes in 15 cell types obtained from Human Protein Atlas. H, Schematic model of the germ cell–like program in HPV-driven cancer.
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 3 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
Oncogenic HPVs induce a germ cell–like transcriptional program conserved throughout HPV-driven cancers. A, Overview of the random forest (RF) feature selection and machine learning procedure to identify a transcriptional fingerprint of HPV-driven oncogenesis. CESC and HNSCC expression data were annotated with HPV status (data acquisition), commonly differentially expressed genes between HPV+ and HPV− were identified (data preparation), and 12 protein-coding signature genes (RF12) were identified (feature selection). Four different machine learning models were trained with RF12 on a subset of DPA, CESC, and HNSCC samples (model training); the model with the best hyperparameters was evaluated using the withheld sample subset and used to classify Genotype-Tissue Expression (GTEx), skin warts, or normal skin expression data (deployment). B, Contribution of RF12 signature genes to cumulative feature importance (%) to discriminate between HPV+ and HPV− tumor samples. C, Uniform manifold approximation and projection (UMAP) dimensionality reduction of RF12 expression in DPA, CESC, HNSCC, and skin warts. D, HPV+ probability scores were calculated by RF12 for CESC, HNSCC, DPA, skin warts, and normal skin. For CESC, HNSCC, and DPA, the test set samples are displayed. E, HPV+ probability scores for HNSCC calculated for CDKN2A and SYCP2 alone, the combination of CDKN2A and SYCP2 (RF2), and RF12. F, HPV+ probability scores were calculated by RF12 for 31 normal tissues obtained from the GTEx database. G, Expression levels of RF12 genes in 15 cell types obtained from Human Protein Atlas. H, Schematic model of the germ cell–like program in HPV-driven cancer.
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
HPV42 integration sites in DPA.
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
HPV42 integration sites in DPA.